Cellular Oncology

Papers
(The TQCC of Cellular Oncology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma169
Acidity and hypoxia of tumor microenvironment, a positive interplay in extracellular vesicle release by tumor cells81
Low-dose SAHA enhances CD8+ T cell-mediated antitumor immunity by boosting MHC I expression in non-small cell lung cancer70
Retraction Note: Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications49
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy43
Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b+CD64+ patients with acute myeloid leukemia42
YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models41
O-GlcNAcylation of TRIM29 and OGT translation forms a feedback loop to promote adaptive response of PDAC cells to glucose deficiency38
Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway37
TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells36
Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis35
Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway34
LncRNA CCAT2 promotes malignant progression of metastatic gastric cancer through regulating CD44 alternative splicing33
Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy32
The development of in vitro organotypic 3D vulvar models to study tumor-stroma interaction and drug efficacy32
Single-cell RNA transcriptomic analyses of tumor microenvironment of ovarian metastasis in gastric cancer31
Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis31
COLEC10 inhibits the stemness of hepatocellular carcinoma by suppressing the activity of β-catenin signaling30
Application of circulating tumour cells to predict response to treatment in head and neck cancer29
Chordoma cells possess bone-dissolving activity at the bone invasion front29
Marine derived macrolide bryostatin 4 inhibits the TGF-β signaling pathway against acute erythroleukemia27
Deciphering the molecular landscape: evolutionary progression from gynecomastia to aggressive male breast cancer27
LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation26
Characterization and proteomic analysis of plasma-derived small extracellular vesicles in locally advanced rectal cancer patients24
Unveiling therapeutic avenues targeting xCT in head and neck cancer23
The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8/miR-181a-5p axis22
HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma21
Cell death in glioblastoma and the central nervous system21
CDK7 blockade suppresses super‐enhancer‐associated oncogenes in bladder cancer21
Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production21
A review on the functional characteristics of the c-Myeloproliferative Leukaemia (c-MPL) gene and its isoforms21
Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer20
The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma19
Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition19
SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer18
Bile acids increase intestinal marker expression via the FXR/SNAI2/miR-1 axis in the stomach18
Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test18
MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer18
Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer17
Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma17
RETRACTED ARTICLE: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling17
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma17
Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression17
Mapping the immune terrain in lung adenocarcinoma progression: Tfh-like cells in tertiary lymphoid structures16
Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression16
Multi-dimensional characterization of apoptosis in the tumor microenvironment and therapeutic relevance in melanoma16
Targeting Dectin-1 and or VISTA enhances anti-tumor immunity in melanoma but not colorectal cancer model16
Pathways and outputs orchestrated in tumor microenvironment cells by hypoxia-induced tumor-derived exosomes in pan-cancer16
Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling16
Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy16
Asymmetric post-translational modifications regulate the nuclear translocation of STAT3 homodimers in response to leukemia inhibitory factor15
FUT8 is regulated by miR‐122‐5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling15
Correction to: Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study15
In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression15
ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer15
Publisher Correction to: RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin15
The therapeutic potential of exosomes in lung cancer15
Correction to: Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis15
Correction to: Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling14
Correction to: H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis14
Correction to: CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer14
Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma13
CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation13
STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma13
Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis13
Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer13
Correction to: Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution12
Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma12
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer12
ADAR1 enhances tumor proliferation and radioresistance in non-small cell lung cancer by interacting with Rad1812
DNA-methylome-derived epigenetic fingerprint as an immunophenotype indicator of durable clinical immunotherapeutic benefits in head and neck squamous cell carcinoma12
Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion12
FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis12
E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities12
Methionine-producing tumor micro(be) environment fuels growth of solid tumors12
Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN111
Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration11
SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma11
Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis11
TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway11
Optimizing the spatial immune landscape of CD103+CD8+ tissue-resident memory T cells in non-small cell lung cancer by neoadjuvant chemotherapy11
ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways11
RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin11
Construction and validation of a regulatory T cells-based classification of renal cell carcinoma: an integrated bioinformatic analysis and clinical cohort study11
IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells11
Lactate score classification of hepatocellular carcinoma helps identify patients with tumors that respond to immune checkpoint blockade therapy10
Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation10
AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis10
Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity10
FGF19 promotes nasopharyngeal carcinoma progression by inducing angiogenesis via inhibiting TRIM21-mediated ANXA2 ubiquitination10
A comprehensive review of SHP2 and its role in cancer10
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing10
Hsa-circ_0058106 induces EMT and metastasis in laryngeal cancer via sponging miR-153 and inducing Twist1 nuclear translocation10
FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer10
Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution10
RETRACTED ARTICLE: The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma10
Annotation and functional characterization of long noncoding RNAs deregulated in pancreatic adenocarcinoma10
Long non‐coding RNA LINC01137 contributes to oral squamous cell carcinoma development and is negatively regulated by miR-22-3p10
Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma10
Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma10
Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex10
OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis9
TIMEAS, a promising method for the stratification of testicular germ cell tumor patients with distinct immune microenvironment, clinical outcome and sensitivity to frontline therapies9
In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPARγ)9
Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma9
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia9
Targeting nucleolin improves sensitivity to chemotherapy in acute lymphoblastic leukemia9
Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study9
Applications and mechanisms of the cyclin-dependent kinase 4/6 inhibitor, PD-0332991, in solid tumors9
VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma9
Survivin degradation by bergenin overcomes pemetrexed resistance9
High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer9
Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming9
0.065732002258301